Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that data on its lead antibacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results